Thursday, January 22, 2026

Consensus Estimates For Amazon’s First Quarter Of 2021

Amazon.com Inc (NASDAQ: AMZN) will be reporting its first quarter financial results on April 29th after market close. Analysts have a consensus $3,993.18 12-month price target on the company, via a total of 47 analysts, with 18 analysts having strong buy ratings. 27 analysts meanwhile have buy ratings and, two analysts have hold ratings. The street high comes from Susquehanna Financial with a $5,200 price target, and the lowest target sits at $3,048 from R5 Capital.

36 analysts have revenue estimates for the first quarter. The mean revenue estimate between all 36 analysts is $104.46 billion; this number has been revised upwards from $95.31 billion at the start of the year. The highest revenue estimate is $107.5 billion, while the lowest is $99.5 billion.

The analyst consensus for net income for the first quarter is $4.96 billion, this is up from the start of the year which was $4.79 billion. The highest net income estimate is $6.14 billion, while the lowest is $3.3 billion.

Onto EBITDA estimates, there are currently 26 analysts who have first-quarter EBITDA estimates. The mean is currently $15.84 billion, with this number having been revised up from $14.84 billion at the start of the year. The street high estimate currently sits at $18 billion in EBITDA and the lowest is $14.13 billion.

Analysts estimate that quarterly earnings per share will come in at $9.54, with this number being slightly revised up from $9.04 at the start of the year. Street high is $12.00 and the lowest estimate is $6.41 per share for the quarter.


Video Articles

Moon River Moly: The Davidson Moly-Copper-Tungsten PEA

Integra: The DeLamar Heap Leach Feasibility Study

Highlander Silver: The Saviour Of Bear Creek Mining

Recommended

Steadright Subsidiary NSM Capital Sarl Applies For License At Titanbeach One

Goliath Resources Accelerates Option Agreement On Golddigger While Reducing NSR

Related News

Canaccord Raises Mind Medicine’s Price Target To $2.00 Following Financing

This morning, Canaccord Genuity raised its 12-month price target on Mind Medicine (NEO: MMED) from...

Monday, November 2, 2020, 10:45:02 AM

Psyched Wellness: Canaccord Pens “Future In Fungi Report”

Yesterday morning, Canaccord Genuity released a primer into five psychedelic companies that they “believe could...

Tuesday, March 9, 2021, 11:49:00 AM

CN Rail: BMO Anticipates Continued Strong Earnings

Canadian National Railway (TSX: CNR) last week released its third-quarter financial and operating results. The...

Thursday, November 3, 2022, 04:38:00 PM

Vintage Wine Estates Sees Canaccord Initiate Coverage With $17.00 Price Target

It’s been a pretty busy month for Vintage Wine Estates (NASDAQ: VWE), a SPAC that...

Monday, June 21, 2021, 03:49:00 PM

Chipotle: First Quarter Analyst Consensus Estimates

Chipotle Mexican Grill (NYSE: CMG) will be reporting their first quarter on April 21st after...

Sunday, April 18, 2021, 04:57:00 PM